EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY 4.0

Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series

Cedric Lau, Charlotte van Kesteren, Yong Xin Cao, Robert M Smeenk, Laura G M Daenen, Jeroen J W M Janssen, Peter E Westerweel

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05924-4 ↗

At a glance

Fallbericht in Annals of Hematology, 2024. Written by Cedric Lau and 6 co-authors. Institution: Department of Clinical Pharmacy, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, Dordrecht, 3318 AT, The Netherlands. s.f.lau@asz.nl. Major MEDLINE topics: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors, Bariatric Surgery. Cited 6 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Bariatric surgery is increasingly performed to treat severe obesity. As a result of anatomical and physiological changes in the gastrointestinal tract, the pharmacokinetics (PK) of oral drugs can be altered, affecting their efficacy and safety. This includes the class of tyrosine kinase inhibitors (TKIs) which are used to treat chronic myeloid leukemia (CML). This case series describes the clinical course of four CML cases with a history of bariatric surgery. The patients used various TKIs (nilotinib, dasatinib, bosutinib, ponatinib, and imatinib) for which 15 drug levels were measured. The measured TKI concentrations were in part subtherapeutic, and highly variable when compared to mean levels measured in the general population. Multiple drug levels were measured in these patients, as the clinicians were aware of the possible impact of bariatric surgery. The drug levels were used as additional input for clinical decision-making. All four patients required TKI switches and/or dose modifications to achieve an effective and tolerable treatment. Eventually, adequate clinical and molecular remissions were achieved in all cases. In summary, TKI concentrations of patients undergoing bariatric surgery may be subtherapeutic. Moreover, there is substantial interindividual and intraindividual variation, which may be explained by the complex interference of bariatric surgery and associated weight loss. For clinical practice, therapeutic drug monitoring is advised in patients with a history of bariatric surgery in case of suboptimal response or loss of response.

Subjects

MeSH terms (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsBariatric SurgeryHumansFemaleMiddle AgedMaleAdultImatinib MesylateDasatinibAniline CompoundsImidazolesPyridazinesObesity, MorbidTyrosine Kinase InhibitorsNitrilesPyrimidinesQuinolines

Author keywords

Bariatric surgeryChronic myeloid leukemiaPharmacokineticsRoux-en-Y gastric bypassSleeve gastrectomyTherapeutic drug monitoringTyrosine kinase inhibitors

Substances

Protein Kinase InhibitorsImatinib MesylateDasatinibAniline CompoundsnilotinibImidazolesPyridazinesbosutinibTyrosine Kinase InhibitorsNitriles

Authors and institutions

  • Department of Clinical Pharmacy, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, Dordrecht, 3318 AT, The Netherlands. s.f.lau@asz.nl.
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. s.f.lau@asz.nl.
  • Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. s.f.lau@asz.nl.
  • Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands. s.f.lau@asz.nl.
  • Department of Clinical Pharmacy, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, Dordrecht, 3318 AT, The Netherlands.
  • Department of Surgery, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, Dordrecht, 3318 AT, The Netherlands.

Cite

APA

Lau, C., van Kesteren, C., Cao, Y. X., Smeenk, R. M., Daenen, L. G. M., Janssen, J. J. W. M., & Westerweel, P. E. (2024). Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series. Annals of Hematology. https://doi.org/10.1007/s00277-024-05924-4

Vancouver

Lau C, van Kesteren C, Cao YX, Smeenk RM, Daenen LGM, Janssen JJWM, et al. Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series. Annals of Hematology. 2024. doi:10.1007/s00277-024-05924-4

BibTeX
@article{Lau2024,
  author = {Lau, Cedric and van Kesteren, Charlotte and Cao, Yong Xin and Smeenk, Robert M and Daenen, Laura G M and Janssen, Jeroen J W M and Westerweel, Peter E},
  title = {Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05924-4}
}
Start for free →